Cargando…
Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease
The research progress of understanding the etiology and pathogenesis of Parkinson's disease (PD) has yet lead to the development of some clinical approaches intended to treat cognitive and behavioral symptoms, such as memory and per-ception disorders. Despite the major advances in different gen...
Autores principales: | Carrera, Iván, Cacabelos, Ramón |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425078/ https://www.ncbi.nlm.nih.gov/pubmed/30479218 http://dx.doi.org/10.2174/1570159X17666181127125704 |
Ejemplares similares
-
Neuroprotective Effect of Nosustrophine in a 3xTg Mouse Model of Alzheimer’s Disease
por: Carrera, Iván, et al.
Publicado: (2023) -
Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer’s and Parkinson’s Diseases
por: Teijido, Oscar, et al.
Publicado: (2018) -
Parkinson’s Disease: From Pathogenesis to Pharmacogenomics
por: Cacabelos, Ramón
Publicado: (2017) -
Epigenetic Studies in the Male APP/BIN1/COPS5 Triple-Transgenic Mouse Model of Alzheimer’s Disease
por: Martínez-Iglesias, Olaia, et al.
Publicado: (2022) -
Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease
por: Ferreira, Carla, et al.
Publicado: (2020)